[-] Show simple item record

dc.contributor.authorGoodemote, Patricia
dc.contributor.authorJamieson, Barbara
dc.date.issued2007-11eng
dc.description.abstractIt's unclear whether disease-modifying antirheumatic agents (DMARDs) as first-line therapy in nonrheumatoid rheumatologic diseases are effective because the question has not been studied. As second-line therapy, the use of some DMARDs appears to be beneficial for patients with psoriatic arthritis (strength of recommendation [SOR: A, based on systematic reviews of good- quality randomized controlled trials) and ankylosing spondylitis (SOR: B, based on systematic reviews of moderate quality trials). Data on the safety and efficacy of DMARDs as second-line therapy for other arthritic conditions is limited (SOR: C, based on small prospective cohort trials).en
dc.identifier.citationJournal of Family Practice, 56(11) 2007: 933+.en
dc.identifier.urihttp://hdl.handle.net/10355/3596
dc.publisherFamily Physicians Inquiries Networken
dc.relation.ispartofClinical Inquiries, 2007 (MU)en
dc.relation.ispartofcommunityUniversity of Missouri-Columbia. School of Medicine. Department of Family and Community Medicine. Family Physicians Inquiries Network
dc.subjectankylosing spondylitisen
dc.subject.lcshAntirheumatic agentsen
dc.subject.lcshPsoriatic arthritis -- Treatmenten
dc.subject.lcshRheumatism -- Treatmenten
dc.titleAre DMARDs effective for rheumatologic diseases besides rheumatoid arthritis?en
dc.typeArticleen


Files in this item

[PDF]

This item appears in the following Collection(s)

[-] Show simple item record